跳至主要内容
临床试验/CTRI/2025/02/080632
CTRI/2025/02/080632尚未招募2/3 期

Comparing the Effect of Bolus Intravenous Dexmedetomidine Vs Magnesium Sulphate On Onset of Atracurium using a TOF Monitor-A Randomised Controlled Trial

DR ANAND S1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2025年3月5日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
75
试验地点
1
主要终点
Time required for TOF value to change from 4 to 0

研究概览

简要总结

•Muscle relaxation is an important component in delivering of anesthesia. Non-depolarizing neuromuscular blocking agents are widely used in maintenance of the neuromuscular relaxation.

•MgSO4, which acts as an antagonist at N-methyl-D-aspartate receptors, has an effect on neuromuscular transmission.

•It potentiates the neuromuscular block produced by nondepolarizing neuromuscular blocking agents.

•Alpha2- adrenergic agonists like Dexmedetomidine potentiate NMBA action by increasing NMBA plasma concentration

•Our goal is to compare the onset of action of Atracurium using a TOF monitor after a bolus of Dexmedetomidine or Magnesium Sulphate during induction and compare with a control group.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • ASA Grade I and Grade II patients b.
  • Age 18 yrs-60yrs.
  • Elective surgeries.

排除标准

  • 未提供

结局指标

主要结局

Time required for TOF value to change from 4 to 0

时间窗: Baseline | After drug changes | Pre intubation | Post intubation

次要结局

  • Time required for TOF value to change from 0 to 1(30 mins,45 mins,60 mins)

研究者

发起方
DR ANAND S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr.Harshanaa.G

Chettinad Academy of Research and Education

研究点 (1)

Loading locations...

相似试验